In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5,556 recent clinical isolates from five medical centers.

In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5,556 recent clinical isolates from five medical centers. by Sader HS, Jones RN, Washington JA, Murray PR, Gerlach EH, Allen SD and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1993; 17 (2): 143-150

Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials.

Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials. by Jones RN, Erwin ME, Hager HL and Hohl PE published in Diagn. Microbiol. Infect. Dis. 1993; 17 (3): 225-232

Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result.

Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result. by Jones RN and Zurenko GE published in Diagn. Microbiol. Infect. Dis. 1993; 17 (4): 313-316

Fluoroquinolone (lomefloxacin) international surveillance trial: A report of 30 months of monitoring in vitro activity.

Fluoroquinolone (lomefloxacin) international surveillance trial: A report of 30 months of monitoring in vitro activity. by Jones RN published in Am. J. Med. 1992; 92 (4A): 52S-57S

Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a multicenter, national comparative activity surveillance study. The Ofloxacin Surveillance Group.

Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a multicenter, national comparative activity surveillance study. The Ofloxacin Surveillance Group. by Jones RN, Reller LB, Rosati LA, Erwin ME and Sanchez ML published in Diagn. Microbiol. Infect. Dis. 1992; 15 (5): 425-434

Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.

Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin. by Jones RN and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1992; 15 (8): 693-701

In vitro activity of 43 antimicrobial agents tested against ampicillin- resistant enterococci and Gram-positive species resistant to vancomycin.

In vitro activity of 43 antimicrobial agents tested against ampicillin- resistant enterococci and Gram-positive species resistant to vancomycin. by Yamane N and Jones RN published in Diagn. Microbiol. Infect. Dis. 1991; 14 (4): 337-345

Antimicrobial susceptibility testing trends and accuracy in the United States. A review of the College of American Pathologists Microbiology Surveys, 1972-1989. Microbiology Resource Committee of the College of American Pathologists.

Antimicrobial susceptibility testing trends and accuracy in the United States. A review of the College of American Pathologists Microbiology Surveys, 1972-1989. Microbiology Resource Committee of the College of American Pathologists. by Jones RN and Edson DC published in Arch. Pathol. Lab. Med. 1991; 115 (5): 429-436

Interpretive criteria, quality control guidelines and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae.

Interpretive criteria, quality control guidelines and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae. by Jones RN, Fuchs PC, Washington JA, Gavan TL, Murray PR, Gerlach EH and Thornsberry C published in Diagn. Microbiol. Infect. Dis. 1990; 13 (6): 499-507

Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococci.

Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococci. by Jones RN and Gardiner RV published in Diagn. Microbiol. Infect. Dis. 1989; 12 (3): 271-273